Armata Pharmaceuticals, Inc. (FRA:TG1N)

Armata Pharmaceuticals Revenue

Armata Pharmaceuticals had revenue of $1.16M USD in the quarter ending September 30, 2025, a decrease of -61.02%. This brings the company's revenue in the last twelve months to $5.05M, down -7.55% year-over-year. In the year 2024, Armata Pharmaceuticals had annual revenue of $5.17M with 14.24% growth.

• Revenue (ttm): $5.05M
• Revenue Growth: -7.55%
• P/S Ratio: 47.66
• Revenue / Employee: $84.23K
• Employees: 60
• Market Cap: 205.31M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.17M	645.00K	14.24%
Dec 31, 2023	4.53M	-979.00K	-17.77%
Dec 31, 2022	5.51M	1.03M	23.11%
Dec 31, 2021	4.47M	3.65M	443.62%
Dec 31, 2020	823.00K	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	115.00K	-145.00K	-55.77%
Dec 31, 2016	260.00K	-215.00K	-45.26%
Dec 31, 2015	475.00K	66.00K	16.14%
Dec 31, 2014	409.00K	328.00K	404.94%
Dec 31, 2013	81.00K	-583.00K	-87.80%
Dec 31, 2012	664.00K	-8.05M	-92.38%
Dec 31, 2008	8.72M	-1.61M	-15.62%
Dec 31, 2007	10.33M	468.00K	4.74%
Dec 31, 2006	9.86M	2.99M	43.50%
Dec 31, 2005	6.87M	-	-